tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MURA Stock Latest News

Mural Oncology announces final cash consideration payable on acquisition close
The FlyMural Oncology announces final cash consideration payable on acquisition close
7d ago
MURA
XOMA
Mural Oncology Approves Acquisition by XRA 5 Corp.
PremiumCompany Announcements
Mural Oncology Approves Acquisition by XRA 5 Corp.
1M ago
8K
MURA
Mural Oncology shareholders approve acquisition by XRA 5 Corp.
PremiumThe Fly
Mural Oncology shareholders approve acquisition by XRA 5 Corp.
1M ago
MURA
XOMA
PremiumCompany Announcements
Mural Oncology Plc Announces Acquisition by XOMA Royalty Corporation
2M ago
MURA
PremiumCompany Announcements
Mural Oncology Plc Announces Acquisition Agreement
3M ago
8K
MURA
Mural Oncology PLC trading resumes
PremiumThe FlyMural Oncology PLC trading resumes
3M ago
MURA
Mural Oncology to be acquired by XRA 5 Corp. for $2.035-$2.24 per share in cash
Premium
The Fly
Mural Oncology to be acquired by XRA 5 Corp. for $2.035-$2.24 per share in cash
3M ago
MURA
XOMA
Mural Oncology PLC trading halted, news pending
Premium
The Fly
Mural Oncology PLC trading halted, news pending
3M ago
MURA
Mural Oncology reports Q2 EPS ($2.78) vs ($1.86) last year
PremiumThe Fly
Mural Oncology reports Q2 EPS ($2.78) vs ($1.86) last year
4M ago
MURA
PremiumCompany Announcements
Mural Oncology Plc Elects Directors at Annual Meeting
6M ago
8K
MURA
PremiumPre-Earnings
MURA Upcoming Earnings Report: What to Expect?
7M ago
MURA
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
7M ago
QID
AISP
Unusually active option classes on open April 21st
PremiumThe FlyUnusually active option classes on open April 21st
8M ago
GE
AMC
Mural Oncology to discontinue nemvaleukin development, reduce staff by 90%
Premium
The Fly
Mural Oncology to discontinue nemvaleukin development, reduce staff by 90%
8M ago
MURA
Mural Oncology plans to explore strategic alternatives
Premium
The Fly
Mural Oncology plans to explore strategic alternatives
8M ago
MURA
Mural Oncology price target lowered to $6 from $18 at H.C. Wainwright
PremiumThe Fly
Mural Oncology price target lowered to $6 from $18 at H.C. Wainwright
8M ago
MURA
Mural Oncology halting progress of nemvaleukin trial in ovarian cancer
PremiumThe Fly
Mural Oncology halting progress of nemvaleukin trial in ovarian cancer
8M ago
MRK
MURA
Mural Oncology downgraded to Hold from Buy at JonesResearch
PremiumThe Fly
Mural Oncology downgraded to Hold from Buy at JonesResearch
8M ago
MURA
Mural Oncology downgraded to Outperform from Strong Buy at Raymond James
PremiumThe Fly
Mural Oncology downgraded to Outperform from Strong Buy at Raymond James
8M ago
MURA
Raymond James downgrades Mural Oncology after ovarian cancer failure
PremiumThe FlyRaymond James downgrades Mural Oncology after ovarian cancer failure
8M ago
MURA
Mural Oncology downgraded to Equal Weight from Overweight at Morgan Stanley
Premium
The Fly
Mural Oncology downgraded to Equal Weight from Overweight at Morgan Stanley
8M ago
MURA
Premium
Ratings
Promising Developments in Mural Oncology Plc’s ARTISTRY-7 Trial Boost Buy Rating
9M ago
MURA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >